Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease

Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is a complex disease associated with premature mortality. Its diagnosis is challenging, and the identification of biomarkers causally influenced by NAFLD may be clinically useful. We aimed at identifying blood metabolites causally impacted by NAFLD using two...

Full description

Bibliographic Details
Main Authors: Émilie Gobeil, Ina Maltais-Payette, Nele Taba, Francis Brière, Nooshin Ghodsian, Erik Abner, Jérôme Bourgault, Eloi Gagnon, Hasanga D. Manikpurage, Christian Couture, Patricia L. Mitchell, Patrick Mathieu, François Julien, Jacques Corbeil, Marie-Claude Vohl, Sébastien Thériault, Tõnu Esko, André Tchernof, Benoit J. Arsenault
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Metabolites
Subjects:
non-alcoholic fatty liver disease
tyrosine
biomarker
metabolites
obesity
Mendelian randomization
Online Access:https://www.mdpi.com/2218-1989/12/5/440

Internet

https://www.mdpi.com/2218-1989/12/5/440

Similar Items